木瓜直播

Study highlights another reason to keep RA under control

But hint of benefit suggests the approach might not be a dead end

Reactions from physician and consumer groups were positive, but drugmakers begged to differ

Prices slashed by as much as 79%

Also in TTHealthWatch: blood tests for Alzheimer's

But clinical importance remains uncertain

Survey data show increased healthcare costs, functional impairment, but not as much as expected

Spanish cohort study tracked patients for up to 20 years after diagnosis

Infliximab copycat usage varies widely with payer type

Stanford University group suggests new component to long controversial diagnosis

This could exacerbate disease burden and reduce quality of life, researchers say

A 68-year-old man presented to the doctor with complaints of right shoulder pain, joint stiffness, and decreased range of motion that developed over the last 2 months. Can you diagnose the patient?

Blackness, per se, seen as less important than area socioeconomics

Staves off end-stage renal disease, retrospective study indicates